TRUFF (TRUFF)
0.03
0.00 (0.00%)
Latest Headlines
Red Light Holland subsidiary signs psilocybin supply deal with Paris hospital
June 8, 2026 7:32 AM - StreetInsider
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France
June 8, 2026 7:32 AM - StreetInsider
Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinica
June 4, 2026 7:33 AM - StreetInsider
Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate
May 25, 2026 8:41 AM - StreetInsider
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechani
May 14, 2026 8:34 AM - StreetInsider
Form D Red Light Holland Corp.
May 13, 2026 4:31 PM - SEC Filing
Red Light Holland shareholders approve name change, CFO resigns
May 13, 2026 9:14 AM - StreetInsider
Red Light Holland Announces Shareholder Approval of Name Change and Announces Voting Results from 2026 Annual General and Special Meeting of Shareholders
May 13, 2026 9:14 AM - StreetInsider
Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intell
May 8, 2026 7:31 AM - StreetInsider
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions
May 7, 2026 7:35 AM - StreetInsider
Red Light Holland Announces Intention to Rebrand
May 4, 2026 8:36 AM - StreetInsider
Red Light Holland completes acquisition of Filament Health
April 30, 2026 7:37 AM - StreetInsider
Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution
April 30, 2026 7:36 AM - StreetInsider
Red Light Holland Announces Filament Health Obtains Final Order for Proposed Arrangement
April 29, 2026 7:35 AM - StreetInsider
Red Light Holland Announces Filament Health Shareholder Approval of Acquisition
April 27, 2026 7:38 AM - StreetInsider
Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments
April 24, 2026 8:29 AM - StreetInsider
Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
April 21, 2026 7:00 AM - Globe NewsWire
Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate
April 20, 2026 7:36 AM - StreetInsider
Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments
April 7, 2026 7:33 AM - StreetInsider
Red Light Holland to Support University of California San Francisco's Global Psychedelic Study Through Filament Health's Clinical Network
April 1, 2026 9:22 AM - StreetInsider
Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement
March 23, 2026 8:17 AM - StreetInsider
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate
March 18, 2026 8:17 AM - StreetInsider
Full Article List
